肌少症诊断标准从AWGS2019更新至AWGS2025,改变手术患者患病率与术后风险预测
Changing sarcopenia diagnostic criteria from AWGS2019 to 2025 impacts prevalence and postoperative risk prediction
779例择期手术患者按AWGS2025重新分类后,肌少症患病率为23.9%,与改良AWGS2019的23.4%接近,但43.7%原先被判为非肌少症的患者被重新归为肌力低下,这部分人出院后转入社区医院而非回家的风险更高(校正相对危险度2.23,95%置信区间1.40–3.56,p<0.001)。
- Article
- Open access
- Published: 26 October 2026
- Ling Liu ORCID: orcid.org/0000-0001-8902-60011,2,
- Hui San Chin1,2,
- Li Feng Tan3,4,
- Nurimah Binte Juri5,
- Siew Chen Anastasia Ghui5,
- Ying Xuan Lek5,
- Fei Yang Tan5,
- Xiuyi Kwek1,2,
- Pei-Ju Liao1,2,
- Alexandra Louise Rei-Min Wee1,2,
- Bin Tean Teh6,7,
- Liang-Kun Chen ORCID: orcid.org/0000-0002-2387-85088,9,10 &
- …
- Frederick H Koh ORCID: orcid.org/0000-0002-3717-44801,2,4,6,11
Communications Medicine (2026) Cite this article
We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.
Abstract
Background
The Asian Working Group for Sarcopenia (AWGS) updated its diagnostic criteria in 2025, shifting focus from diagnosing sarcopenia in older adults towards promoting muscle health across the lifespan. How this update impacts the diagnosis prevalence and prediction for health outcomes in surgical patients is unknown.
Methods
We analyzed elective surgical patients previously assessed using the modified 2019 criteria, reclassifying them under the 2025 criteria, a body-mass-index-adjusted variant, and a muscle-specific-strength variant.
Results
Here we show that among 779 patients (56.0% male participants; mean age 65.5 ± 11.3 years), sarcopenia prevalence is similar between the modified AWGS2019 (23.4%) and AWGS2025 (23.9%) criteria. Under AWGS2025, 43.7% of patients previously classified as non-sarcopenia are reclassified as having low muscle strength. They are more likely to be discharged to a community hospital rather than home (adjusted relative risk 2.23, 95% confidence interval 1.40–3.56, p < 0.001). The body-mass-index-adjusted variant increases prevalence to 29.8%, with 124 of 261 (47.5%) low-muscle-strength patients reclassified as having sarcopenia, predominantly in the presence of obesity and showing a non-significant trend toward better short-term outcomes. The muscle-specific-strength variant decreases prevalence to 16.8% and performs less well than standard AWGS2025 in reclassifying risk for prolonged hospitalization.
Conclusions
The AWGS2025 criteria further stratify patients previously classified as non-sarcopenia, identifying a subgroup with low muscle strength and normal muscle mass who require more post-discharge support. We recommend the body-mass-index-adjusted variant for routine surgical practice to optimize resource allocation and personalized perioperative care.
Plain Language Summary
As people age, they can lose muscle mass and strength and develop a condition called sarcopenia. In 2025, the Asian Working Group for Sarcopenia (AWGS) changed how sarcopenia is diagnosed. It was unclear how this change, from AWGS2019 to AWGS2025, would affect patients after surgery. We studied 779 patients who had major surgery and compared their postoperative outcomes. AWGS2025 did not change sarcopenia prevalence significantly, but identified a subgroup with weak muscle strength despite having normal muscle mass. These patients were more likely to need extra support after discharge. We recommend a version of AWGS2025 that accounts for body mass index, which better identifies patients at risk, helping doctors plan care and allocate resources after surgery.
Acknowledgements
Not applicable.
Funding
This work was supported in part by SingHealth Duke-NUS Academic Medicine Research Grant AM/RM010/2024 and Sengkang General Hospital Centre Grant Seed Grant 003.
Author information
Authors and Affiliations
Research Office, Sengkang General Hospital, Singapore, Singapore
Ling Liu, Hui San Chin, Xiuyi Kwek, Pei-Ju Liao, Alexandra Louise Rei-Min Wee & Frederick H Koh
SingHealth Duke-NUS Muscle Health Programme, SingHealth, Singapore, Singapore
Ling Liu, Hui San Chin, Xiuyi Kwek, Pei-Ju Liao, Alexandra Louise Rei-Min Wee & Frederick H Koh
Healthy Ageing Programme, Alexandra Hospital, National University Health System, Singapore, Singapore
Li Feng Tan
Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
Li Feng Tan & Frederick H Koh
Department of Population Health and Integrated Care, Sengkang General Hospital, Singapore, Singapore
Nurimah Binte Juri, Siew Chen Anastasia Ghui, Ying Xuan Lek & Fei Yang Tan
Duke-NUS Medical School, Singapore, Singapore
Bin Tean Teh & Frederick H Koh
National Cancer Centre Singapore, Singapore, Singapore
Bin Tean Teh
Center for Geriatrics and Gerontology, Taipei Veterans General Hospital, Taipei, Taiwan
Liang-Kun Chen
Center for Healthy Longevity and Aging Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan
Liang-Kun Chen
Taipei Municipal Gan-Dau Hospital, Taipei, Taiwan
Liang-Kun Chen
Department of Colorectal Surgery, Sengkang General Hospital, Singapore, Singapore
Frederick H Koh
Authors
- Ling Liu
- Hui San Chin
- Li Feng Tan
- Nurimah Binte Juri
- Siew Chen Anastasia Ghui
- Ying Xuan Lek
- Fei Yang Tan
- Xiuyi Kwek
- Pei-Ju Liao
- Alexandra Louise Rei-Min Wee
- Bin Tean Teh
- Liang-Kun Chen
- Frederick H Koh
Corresponding author
Correspondence to Frederick H Koh.
Ethics declarations
Competing Interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Liu, L., Chin, H.S., Tan, L.F. et al. Changing sarcopenia diagnostic criteria from AWGS2019 to 2025 impacts prevalence and postoperative risk prediction. Commun Med (2026). https://doi.org/10.1038/s43856-026-01990-z
Received: 27 March 2026
Accepted: 08 October 2026
Published: 26 October 2026
DOI: https://doi.org/10.1038/s43856-026-01990-z
来源:Nature 健康护理主题 · nature.com